Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zabrina L Brumme

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1David J H F Knapp, Zabrina L Brumme, Sheng Yuan Huang, et al.
Scientific Reports|December 4, 2015
Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstructionAnh Q Le, Jeremy Taylor, Winnie Dong, et al.
Journal of Virology|July 17, 2015
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry ReceptorsMako Toyoda, Yoko Ogata, Macdonald Mahiti, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Retrovirology|January 11, 2020
Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case studyHanwei Sudderuddin, Natalie N Kinloch, Steven W Jin, et al.
Antiviral Therapy|May 14, 2003
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapyZabrina L Brumme, Keith J Chan, Winnie W Y Dong, et al.
Plos Pathogens|November 4, 2022
HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapyAniqa Shahid, Bradley R Jones, Julia S W Yang, et al.
Journal of Virology|January 13, 2012
Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacityJaclyn K Wright, Vanessa L Naidoo, Zabrina L Brumme, et al.
AIDS Research and Human Retroviruses|June 29, 2016
Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early InfectionRaabya Rossenkhan, Iain J MacLeod, Zabrina L Brumme, et al.
Frontiers in Virology (Lausanne, Switzerland)|June 17, 2024
No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originatedNelson Sonela, Jaclyn Mann, Celestin Godwe, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1David J H F Knapp, Zabrina L Brumme, Sheng Yuan Huang, et al.
Scientific Reports|December 4, 2015
Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstructionAnh Q Le, Jeremy Taylor, Winnie Dong, et al.
Journal of Virology|July 17, 2015
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry ReceptorsMako Toyoda, Yoko Ogata, Macdonald Mahiti, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Retrovirology|January 11, 2020
Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case studyHanwei Sudderuddin, Natalie N Kinloch, Steven W Jin, et al.
Antiviral Therapy|May 14, 2003
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapyZabrina L Brumme, Keith J Chan, Winnie W Y Dong, et al.
Plos Pathogens|November 4, 2022
HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapyAniqa Shahid, Bradley R Jones, Julia S W Yang, et al.
Journal of Virology|January 13, 2012
Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacityJaclyn K Wright, Vanessa L Naidoo, Zabrina L Brumme, et al.
AIDS Research and Human Retroviruses|June 29, 2016
Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early InfectionRaabya Rossenkhan, Iain J MacLeod, Zabrina L Brumme, et al.
Frontiers in Virology (Lausanne, Switzerland)|June 17, 2024
No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originatedNelson Sonela, Jaclyn Mann, Celestin Godwe, et al.
Pageof 21